Universal Technical Institute trims 2026 outlook
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Universal Technical Institute, Inc. reported fiscal Q3 2026 revenue of $218.9 million, up 7.2% year over year, while operating income fell to $3.2 million and net income to $2.3 million, or $0.04 per diluted share, as operating expenses rose with strategic growth initiatives.
Adjusted EBITDA declined 27.8% to $18.2 million, reflecting about $9.0 million of growth investments. Average full-time active students grew 5.8% to 25,131, and total new student starts increased 10.9% to 6,342, supported by newer campuses such as UTI-Atlanta opening ahead of internal expectations.
The company ended June 30, 2026 with total available liquidity of $180.5 million and total debt of $160.0 million, including $95.0 million on its revolving credit facility, after incurring $85.4 million of year-to-date cash capex. For fiscal 2026, it now guides to revenue of $893–$900 million, net income of $32–$36 million, adjusted EBITDA of $100–$103 million, and adjusted free cash flow between $(20) million and $0, citing timing and mix factors plus approximately $35 million of growth investments, while reaffirming longer-term North Star Phase II targets.
Positive
- Revenue and enrollment growth remain solid: Q3 2026 revenue rose 7.2% to $218.9 million, with average full-time active students up 5.8% to 25,131 and new student starts up 10.9% to 6,342, indicating continued demand across both UTI and Concorde divisions.
- Strong liquidity supports ongoing investments: Total available liquidity at June 30, 2026 was $180.5 million, against total debt of $160.0 million, providing financial capacity to fund new campuses, program expansions and the multi-year optimization and restructuring under the North Star strategy.
Negative
- Profitability contracted sharply: Q3 2026 net income fell to $2.3 million from $10.7 million a year earlier, while adjusted EBITDA declined 27.8% to $18.2 million, as operating expenses grew 13.4% and the company absorbed $9.0 million of strategic growth expenses in the quarter.
- Fiscal 2026 outlook was reduced: Revenue guidance was cut to $893–$900 million from $905–$915 million, net income to $32–$36 million from $40–$45 million, adjusted EBITDA to $100–$103 million from $114–$119 million, and adjusted free cash flow to $(20)–$0 million from $20–$25 million.
Filing Explained
Phase I of UTI’s operating-model restructuring is implemented; the multi-year transition has begun, but later phases remain planned.
This Form 8-K discloses a current operating-model transition: the company says it has unified all programs under one corporate structure and is beginning a multi-year optimization effort.
The disclosed mechanics are centralized enterprise functions, standardized processes, streamlined operations, and resource realignment across the business; this changes how the company is organized and operated, not the number or ownership of common shares.
Phase I of the restructuring was approved and implemented in
The filing states that its results release, investor presentation, and financial supplement were furnished rather than filed, and are not incorporated by reference except through a specific later filing.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
Adjusted free cash flow financial
North Star strategy financial
Title IV Program regulatory
90/10 Ratio financial
Earnings Snapshot
For fiscal 2026, the company guides to revenue of $893–$900 million, net income of $32–$36 million, diluted EPS of $0.57–$0.64, adjusted EBITDA of $100–$103 million and adjusted free cash flow between $(20) million and $0, incorporating approximately $110 million of cash capex.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Universal Technical Institute's (UTI) Q3 2026 revenues and earnings?
How did Universal Technical Institute's (UTI) student enrollment perform in Q3 2026?
What fiscal 2026 financial guidance did Universal Technical Institute (UTI) provide?
Why did Universal Technical Institute's (UTI) profits decline despite higher Q3 2026 revenue?
What is Universal Technical Institute's (UTI) liquidity and debt position as of June 30, 2026?
What long-term financial targets has Universal Technical Institute (UTI) set under its North Star strategy?
AI-generated analysis. How Rhea-AI works. Not financial advice.
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices) | (Zip Code) | ||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Exhibit No. | Description | |||||||
| 99.1 | Press Release of Universal Technical Institute, Inc., dated August 5, 2026 | |||||||
| 99.2 | Investor Presentation dated August 5, 2026 | |||||||
| 99.3 | Q3 2026 Financial Supplement dated August 5, 2026 | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| UNIVERSAL TECHNICAL INSTITUTE, INC. | ||||||||||||||
| By: | /s/ Bruce Schuman | |||||||||||||
| Name: | Bruce Schuman | |||||||||||||
| Title: | Executive Vice President and Chief Financial Officer | |||||||||||||
| Previous | Updated | ||||||||||
FY 2026 | FY 2026 | ||||||||||
| ($ in millions, except EPS) | Guidance | Guidance | |||||||||
| New student starts | 31,500 - 33,000 | 31,900 - 32,300 | |||||||||
| Revenue | $905 - 915 | $893 - 900 | |||||||||
| Net Income | $40 - 45 | $32 - 36 | |||||||||
| Diluted EPS | $0.71 - 0.80 | $0.57 - 0.64 | |||||||||
Adjusted EBITDA(1) | $114 - 119 | $100 - 103 | |||||||||
Adjusted free cash flow(1)(2) | $20 - 25 | $(20) - 0 | |||||||||
| Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenues | $ | 218,907 | $ | 204,298 | $ | 661,153 | $ | 613,174 | |||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Educational services and facilities | 118,334 | 105,604 | 346,211 | 308,233 | |||||||||||||||||||
| Selling, general and administrative | 97,328 | 84,542 | 295,671 | 246,458 | |||||||||||||||||||
| Total operating expenses | 215,662 | 190,146 | 641,882 | 554,691 | |||||||||||||||||||
| Income from operations | 3,245 | 14,152 | 19,271 | 58,483 | |||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||
| Interest income | 764 | 1,445 | 3,370 | 4,833 | |||||||||||||||||||
| Interest expense | (1,013) | (1,394) | (2,977) | (4,724) | |||||||||||||||||||
| Other income (expense), net | 103 | 149 | 30 | 123 | |||||||||||||||||||
| Total other (expense) income, net | (146) | 200 | 423 | 232 | |||||||||||||||||||
| Income before income taxes | 3,099 | 14,352 | 19,694 | 58,715 | |||||||||||||||||||
| Income tax expense | (820) | (3,689) | (4,155) | (14,453) | |||||||||||||||||||
| Net income | $ | 2,279 | $ | 10,663 | $ | 15,539 | $ | 44,262 | |||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Net income per share - basic | $ | 0.04 | $ | 0.20 | $ | 0.28 | $ | 0.82 | |||||||||||||||
| Net income per share - diluted | $ | 0.04 | $ | 0.19 | $ | 0.28 | $ | 0.80 | |||||||||||||||
| Weighted average number of shares outstanding: | |||||||||||||||||||||||
| Basic | 55,075 | 54,412 | 54,891 | 54,260 | |||||||||||||||||||
| Diluted | 55,935 | 55,635 | 55,818 | 55,502 | |||||||||||||||||||
| June 30, 2026 | September 30, 2025 | ||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | 130,060 | $ | 127,361 | |||||||
| Restricted cash | 5,871 | 6,769 | |||||||||
| Short-term investments | 40,060 | 41,784 | |||||||||
| Receivables, net | 49,824 | 46,078 | |||||||||
| Notes receivable, current portion | 6,707 | 6,597 | |||||||||
| Prepaid expenses | 17,456 | 12,526 | |||||||||
| Other current assets | 8,103 | 5,517 | |||||||||
| Total current assets | 258,081 | 246,632 | |||||||||
| Property and equipment, net | 338,764 | 285,852 | |||||||||
| Goodwill | 28,459 | 28,459 | |||||||||
| Intangible assets, net | 25,535 | 17,352 | |||||||||
| Notes receivable, less current portion | 45,439 | 41,109 | |||||||||
| Right-of-use assets for operating leases | 182,004 | 178,861 | |||||||||
| Deferred tax assets, net | 2,324 | 4,283 | |||||||||
| Other assets | 17,256 | 23,591 | |||||||||
| Total assets | $ | 897,862 | $ | 826,139 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Accounts payable and accrued expenses | $ | 105,763 | $ | 104,644 | |||||||
| Deferred revenue | 70,720 | 91,525 | |||||||||
| Operating lease liabilities, current portion | 14,814 | 16,967 | |||||||||
| Long-term debt, current portion | 2,993 | 2,865 | |||||||||
| Other current liabilities | 4,004 | 13,670 | |||||||||
| Total current liabilities | 198,294 | 229,671 | |||||||||
| Deferred tax liabilities, net | 4,144 | 4,144 | |||||||||
| Operating lease liabilities | 184,623 | 174,838 | |||||||||
| Long-term debt | 157,041 | 84,234 | |||||||||
| Other liabilities | 9,454 | 5,142 | |||||||||
| Total liabilities | 553,556 | 498,029 | |||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity: | |||||||||||
Common stock, $0.0001 par value, 100,000 shares authorized, 55,177 and 54,512 shares issued, 55,095 and 54,430 shares outstanding as of June 30, 2026 and September 30, 2025, respectively. | 6 | 5 | |||||||||
| Paid-in capital | 226,727 | 226,031 | |||||||||
Treasury stock, at cost, 82 shares as of June 30, 2026 and September 30, 2025. | (365) | (365) | |||||||||
| Retained earnings | 117,066 | 101,527 | |||||||||
| Accumulated other comprehensive income | 872 | 912 | |||||||||
| Total shareholders’ equity | 344,306 | 328,110 | |||||||||
| Total liabilities and shareholders’ equity | $ | 897,862 | $ | 826,139 | |||||||
| Nine Months Ended June 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 15,539 | $ | 44,262 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization | 28,361 | 24,452 | |||||||||
| Amortization of right-of-use assets for operating leases | 19,656 | 17,492 | |||||||||
| Provision for credit losses | 22,403 | 15,063 | |||||||||
| Stock-based compensation | 9,426 | 6,402 | |||||||||
| Deferred income taxes | 1,999 | 579 | |||||||||
| Training equipment credits earned, net | 487 | (108) | |||||||||
| Unrealized gain (loss) on interest rate swaps, net of taxes | 121 | (92) | |||||||||
| Other gains (losses), net | 545 | 1,179 | |||||||||
| Changes in assets and liabilities: | |||||||||||
| Receivables | (26,477) | (21,895) | |||||||||
| Prepaid expenses and other current assets | (11,684) | (4,499) | |||||||||
| Other assets | 2,155 | (5,383) | |||||||||
| Notes receivable | (4,440) | (4,051) | |||||||||
| Accounts payable, accrued expenses and other current liabilities | 4,371 | 6,455 | |||||||||
| Deferred revenue | (20,805) | (25,495) | |||||||||
| Income tax payable/receivable | (7,064) | 3,598 | |||||||||
| Operating lease liabilities | (15,167) | (16,758) | |||||||||
| Other liabilities | (2,024) | (975) | |||||||||
| Net cash provided by operating activities | 17,402 | 40,226 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of property and equipment | (80,900) | (25,499) | |||||||||
| Capitalized costs for intangible assets | (4,496) | — | |||||||||
| Purchase of investments | (57,347) | (54,648) | |||||||||
| Proceeds from sale of investments | 31,668 | — | |||||||||
| Proceeds received upon maturity of investments | 31,300 | 1,874 | |||||||||
| Proceeds from insurance policy | 37 | — | |||||||||
| Net cash used in investing activities | (79,738) | (78,273) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Proceeds from revolving credit facility | 195,000 | 6,000 | |||||||||
| Payments on revolving credit facility | (120,000) | (56,000) | |||||||||
| Payment of term loans and finance leases | (2,133) | (2,010) | |||||||||
| Proceeds from stock option exercises | — | 659 | |||||||||
| Payment of payroll taxes on stock-based compensation through shares withheld | (8,730) | (4,675) | |||||||||
| Net cash provided by (used in) financing activities | 64,137 | (56,026) | |||||||||
| Change in cash, cash equivalents and restricted cash | 1,801 | (94,073) | |||||||||
| Cash and cash equivalents, beginning of period | 127,361 | 161,900 | |||||||||
| Restricted cash, beginning of period | 6,769 | 5,572 | |||||||||
| Cash, cash equivalents and restricted cash, beginning of period | 134,130 | 167,472 | |||||||||
| Cash and cash equivalents, end of period | 130,060 | 70,672 | |||||||||
| Restricted cash, end of period | 5,871 | 2,727 | |||||||||
| Cash, cash equivalents and restricted cash, end of period | $ | 135,931 | $ | 73,399 | |||||||
| Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||||
| UTI | Concorde | Total | UTI | Concorde | Total | |||||||||||||||||||||||||||||||||
| Total new student starts | 3,491 | 2,851 | 6,342 | 2,829 | 2,892 | 5,721 | ||||||||||||||||||||||||||||||||
| Year-over-year growth | 23.4 | % | (1.4) | % | 10.9 | % | (3.0) | % | 9.1 | % | 2.8 | % | ||||||||||||||||||||||||||
| Average full-time active students | 14,767 | 10,364 | 25,131 | 14,205 | 9,552 | 23,757 | ||||||||||||||||||||||||||||||||
| Year-over-year growth | 4.0 | % | 8.5 | % | 5.8 | % | 8.9 | % | 18.8 | % | 12.7 | % | ||||||||||||||||||||||||||
| End of period full-time active students | 14,602 | 9,806 | 24,408 | 13,874 | 8,495 | 22,369 | ||||||||||||||||||||||||||||||||
| Year-over-year growth | 5.2 | % | 15.4 | % | 9.1 | % | 9.4 | % | 14.1 | % | 11.1 | % | ||||||||||||||||||||||||||
| Nine Months Ended June 30, 2026 | Nine Months Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||||
| UTI | Concorde | Total | UTI | Concorde | Total | |||||||||||||||||||||||||||||||||
| Total new student starts | 10,494 | 8,866 | 19,360 | 9,173 | 8,511 | 17,684 | ||||||||||||||||||||||||||||||||
| Year-over-year growth | 14.4% | 4.2% | 9.5% | 13.7% | 16.2% | 14.9% | ||||||||||||||||||||||||||||||||
| Average full-time active students | 15,557 | 10,568 | 26,125 | 14,815 | 9,659 | 24,474 | ||||||||||||||||||||||||||||||||
| Year-over-year growth | 5.0% | 9.4% | 6.7% | 7.9% | 16.9% | 11.3% | ||||||||||||||||||||||||||||||||
| End of period full-time active students | 14,602 | 9,806 | 24,408 | 13,874 | 8,495 | 22,369 | ||||||||||||||||||||||||||||||||
| Year-over-year growth | 5.2% | 15.4% | 9.1% | 9.4% | 14.1% | 11.1% | ||||||||||||||||||||||||||||||||
| Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | UTI | Concorde | Corporate | Consolidated | ||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | $ | 138,015 | $ | 80,892 | $ | — | $ | 218,907 | $ | 131,462 | $ | 72,836 | $ | — | $ | 204,298 | |||||||||||||||||||||||||||||||||||||
| Total operating expenses | 132,201 | 77,721 | 5,740 | 215,662 | 113,737 | 71,713 | 4,696 | 190,146 | |||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | 5,020 | 3,130 | (5,871) | 2,279 | 16,439 | 1,084 | (6,860) | 10,663 | |||||||||||||||||||||||||||||||||||||||||||||
| Nine Months Ended June 30, 2026 | Nine Months Ended June 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | UTI | Concorde | Corporate | Consolidated | ||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | $ | 423,577 | $ | 237,576 | $ | — | $ | 661,153 | $ | 397,168 | $ | 216,006 | $ | — | $ | 613,174 | |||||||||||||||||||||||||||||||||||||
| Total operating expenses | 397,732 | 230,815 | 13,335 | 641,882 | 339,181 | 204,301 | 11,209 | 554,691 | |||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | 23,420 | 6,683 | (14,564) | 15,539 | 54,315 | 11,591 | (21,644) | 44,262 | |||||||||||||||||||||||||||||||||||||||||||||
Three Months Ended June 30, 2026 | ||||||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | |||||||||||||||||||||||
| Operating Expenses | ||||||||||||||||||||||||||
| Compensation and benefits | $ | 58,274 | $ | 36,699 | $ | 19,898 | $ | 114,871 | ||||||||||||||||||
| Advertising | 16,243 | 9,696 | 208 | 26,147 | ||||||||||||||||||||||
| Occupancy | 10,882 | 6,655 | 976 | 18,513 | ||||||||||||||||||||||
| Student related | 12,326 | 5,494 | — | 17,820 | ||||||||||||||||||||||
| General operations | 6,157 | 4,605 | 5,634 | 16,396 | ||||||||||||||||||||||
| Depreciation and amortization | 7,284 | 2,751 | 375 | 10,410 | ||||||||||||||||||||||
| Professional and contract services | 2,318 | 1,297 | 4,258 | 7,873 | ||||||||||||||||||||||
| Other expenses | 1,969 | 711 | 952 | 3,632 | ||||||||||||||||||||||
| Corporate support | 16,748 | 9,813 | (26,561) | — | ||||||||||||||||||||||
| Total Operating Expenses | $ | 132,201 | $ | 77,721 | $ | 5,740 | $ | 215,662 | ||||||||||||||||||
Three Months Ended June 30, 2025 | ||||||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | |||||||||||||||||||||||
| Operating Expenses | ||||||||||||||||||||||||||
| Compensation and benefits | $ | 51,230 | $ | 34,122 | $ | 17,423 | $ | 102,775 | ||||||||||||||||||
| Advertising | 15,008 | 7,534 | 153 | 22,695 | ||||||||||||||||||||||
| Occupancy | 9,920 | 6,494 | 233 | 16,647 | ||||||||||||||||||||||
| Student related | 7,671 | 6,122 | — | 13,793 | ||||||||||||||||||||||
| General operations | 5,532 | 5,123 | 3,146 | 13,801 | ||||||||||||||||||||||
| Depreciation and amortization | 6,048 | 1,939 | 328 | 8,315 | ||||||||||||||||||||||
| Professional and contract services | 2,360 | 1,264 | 4,590 | 8,214 | ||||||||||||||||||||||
| Other expenses | 1,648 | 1,182 | 1,076 | 3,906 | ||||||||||||||||||||||
| Corporate support | 14,320 | 7,933 | (22,253) | — | ||||||||||||||||||||||
| Total Operating Expenses | $ | 113,737 | $ | 71,713 | $ | 4,696 | $ | 190,146 | ||||||||||||||||||
| Nine Months Ended June 30, 2026 | ||||||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | |||||||||||||||||||||||
| Operating Expenses | ||||||||||||||||||||||||||
| Compensation and benefits | $ | 169,703 | $ | 109,649 | $ | 58,410 | $ | 337,762 | ||||||||||||||||||
| Advertising | 53,213 | 28,988 | 607 | 82,808 | ||||||||||||||||||||||
| Occupancy | 32,035 | 19,255 | 2,866 | 54,156 | ||||||||||||||||||||||
| Student related | 34,648 | 16,588 | — | 51,236 | ||||||||||||||||||||||
| General operations | 21,818 | 13,534 | 16,283 | 51,635 | ||||||||||||||||||||||
| Depreciation and amortization | 20,326 | 6,991 | 1,044 | 28,361 | ||||||||||||||||||||||
| Professional and contract services | 7,516 | 3,857 | 13,212 | 24,585 | ||||||||||||||||||||||
| Other expenses | 5,862 | 2,345 | 3,132 | 11,339 | ||||||||||||||||||||||
| Corporate support | 52,611 | 29,608 | (82,219) | — | ||||||||||||||||||||||
| Total Operating Expenses | $ | 397,732 | $ | 230,815 | $ | 13,335 | $ | 641,882 | ||||||||||||||||||
| Nine Months Ended June 30, 2025 | ||||||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | |||||||||||||||||||||||
| Operating Expenses | ||||||||||||||||||||||||||
| Compensation and benefits | $ | 153,120 | $ | 98,130 | $ | 49,575 | $ | 300,825 | ||||||||||||||||||
| Advertising | 44,536 | 22,791 | 551 | 67,878 | ||||||||||||||||||||||
| Occupancy | 28,245 | 18,206 | 674 | 47,125 | ||||||||||||||||||||||
| Student related | 26,511 | 17,010 | — | 43,521 | ||||||||||||||||||||||
| General operations | 14,479 | 12,985 | 8,322 | 35,786 | ||||||||||||||||||||||
| Depreciation and amortization | 17,947 | 5,499 | 1,006 | 24,452 | ||||||||||||||||||||||
| Professional and contract services | 7,330 | 3,868 | 13,457 | 24,655 | ||||||||||||||||||||||
| Other expenses | 4,860 | 2,777 | 2,812 | 10,449 | ||||||||||||||||||||||
| Corporate support | 42,153 | 23,035 | (65,188) | — | ||||||||||||||||||||||
| Total Operating Expenses | $ | 339,181 | $ | 204,301 | $ | 11,209 | $ | 554,691 | ||||||||||||||||||
| Three Months Ended June 30, 2026 | |||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | ||||||||||||||||||||
| Net income (loss) | $ | 5,020 | $ | 3,130 | $ | (5,871) | $ | 2,279 | |||||||||||||||
| Interest expense (income), net | 793 | 41 | (585) | 249 | |||||||||||||||||||
| Income tax expense | — | — | 820 | 820 | |||||||||||||||||||
| Depreciation and amortization | 7,284 | 2,751 | 375 | 10,410 | |||||||||||||||||||
| EBITDA | 13,097 | 5,922 | (5,261) | 13,758 | |||||||||||||||||||
| Stock-based compensation expense | 475 | 248 | 2,247 | 2,970 | |||||||||||||||||||
| Integration-related costs for completed acquisitions | — | — | 421 | 421 | |||||||||||||||||||
| Restructuring costs | 712 | 230 | 154 | 1,096 | |||||||||||||||||||
| Adjusted EBITDA, non-GAAP | $ | 14,284 | $ | 6,400 | $ | (2,439) | $ | 18,245 | |||||||||||||||
| Three Months Ended June 30, 2025 | |||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | ||||||||||||||||||||
| Net income (loss) | $ | 16,439 | $ | 1,084 | $ | (6,860) | $ | 10,663 | |||||||||||||||
| Interest expense (income), net | 1,288 | 39 | (1,378) | (51) | |||||||||||||||||||
| Income tax expense | — | — | 3,689 | 3,689 | |||||||||||||||||||
| Depreciation and amortization | 6,048 | 1,939 | 328 | 8,315 | |||||||||||||||||||
| EBITDA | 23,775 | 3,062 | (4,221) | 22,616 | |||||||||||||||||||
| Stock-based compensation expense | 464 | 208 | 1,986 | 2,658 | |||||||||||||||||||
| Adjusted EBITDA, non-GAAP | $ | 24,239 | $ | 3,270 | $ | (2,235) | $ | 25,274 | |||||||||||||||
| Nine Months Ended June 30, 2026 | |||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | ||||||||||||||||||||
| Net income (loss) | $ | 23,420 | $ | 6,683 | $ | (14,564) | $ | 15,539 | |||||||||||||||
| Interest expense (income), net | 2,426 | 79 | (2,898) | (393) | |||||||||||||||||||
| Income tax expense | — | — | 4,155 | 4,155 | |||||||||||||||||||
| Depreciation and amortization | 20,326 | 6,991 | 1,044 | 28,361 | |||||||||||||||||||
| EBITDA | 46,172 | 13,753 | (12,263) | 47,662 | |||||||||||||||||||
| Stock-based compensation expense | 1,454 | 747 | 7,225 | 9,426 | |||||||||||||||||||
| Integration-related costs for completed acquisitions | — | — | 1,356 | 1,356 | |||||||||||||||||||
| Restructuring costs | 712 | 230 | 154 | 1,096 | |||||||||||||||||||
| Adjusted EBITDA, non-GAAP | $ | 48,338 | $ | 14,730 | $ | (3,528) | $ | 59,540 | |||||||||||||||
| Nine Months Ended June 30, 2025 | |||||||||||||||||||||||
| UTI | Concorde | Corporate | Consolidated | ||||||||||||||||||||
| Net income (loss) | $ | 54,315 | $ | 11,591 | $ | (21,644) | $ | 44,262 | |||||||||||||||
| Interest expense (income), net | 3,682 | 114 | (3,905) | (109) | |||||||||||||||||||
| Income tax expense | — | — | 14,453 | 14,453 | |||||||||||||||||||
| Depreciation and amortization | 17,947 | 5,499 | 1,006 | 24,452 | |||||||||||||||||||
| EBITDA | 75,944 | 17,204 | (10,090) | 83,058 | |||||||||||||||||||
| Stock-based compensation expense | 1,370 | 476 | 4,556 | 6,402 | |||||||||||||||||||
| Acquisition-related costs | — | — | 873 | 873 | |||||||||||||||||||
Integration-related costs for completed acquisitions(1) | — | — | (700) | (700) | |||||||||||||||||||
| Restructuring costs | 43 | — | — | 43 | |||||||||||||||||||
| Adjusted EBITDA, non-GAAP | $ | 77,357 | $ | 17,680 | $ | (5,361) | $ | 89,676 | |||||||||||||||
| Nine Months Ended June 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Net cash provided by operating activities, as reported | $ | 17,402 | $ | 40,226 | |||||||
| Purchase of property and equipment | (80,900) | (25,499) | |||||||||
| Capitalized costs for intangible assets | (4,496) | — | |||||||||
| Free cash flow, non-GAAP | (67,994) | 14,727 | |||||||||
| Adjustments: | |||||||||||
Cash outflow (inflow) for integration-related costs for completed acquisitions(1) | 1,986 | (700) | |||||||||
| Cash outflow for acquisition-related costs | — | 873 | |||||||||
| Cash outflow for restructuring costs | 411 | 59 | |||||||||
| Adjusted free cash flow, non-GAAP | $ | (65,597) | $ | 14,959 | |||||||
| Updated | |||||
| Twelve Months Ended | |||||
| September 30, | |||||
2026 | |||||
| Net income | ~$34,000 | ||||
| Interest expense (income), net | ~200 | ||||
| Income tax expense | ~12,500 | ||||
| Depreciation and amortization | ~39,500 | ||||
| EBITDA | ~86,200 | ||||
| Stock-based compensation expense | ~12,300 | ||||
| Integration-related costs for completed acquisitions | ~2,000 | ||||
| Restructuring costs | ~1,000 | ||||
| Adjusted EBITDA, non-GAAP | ~$101,500 | ||||
FY 2026 Guidance Range | ~$100,000 - 103,000 | ||||
| Updated | |||||
| Twelve Months Ended | |||||
| September 30, | |||||
2026 | |||||
| Net cash provided by operating activities | ~$97,000 | ||||
| Purchase of property and equipment & capitalized costs for intangible assets | ~(110,000) | ||||
| Free cash flow, non-GAAP | ~(13,000) | ||||
| Adjustments: | |||||
| Cash outflow for integration-related costs for completed acquisitions | ~2,000 | ||||
| Cash outflow for restructuring costs | ~1,000 | ||||
| Adjusted free cash flow, non-GAAP | ~$(10,000) | ||||
FY 2026 Guidance Range | ~$(20,000) - 0 | ||||